Skip to main content

Advertisement

Log in

Oxaliplatin-related neurotoxicity: is chelation the solution?

  • Practice Point
  • Published:

From Nature Clinical Practice Oncology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Andre T et al. (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350: 2343–2351

    Article  CAS  Google Scholar 

  2. Extra JM et al. (1990) Phase I study of oxaliplatin in patients with advanced cancer. Cancer Chemother Pharmacol 25: 299–303

    Article  CAS  Google Scholar 

  3. Gamelin E et al. (2002) Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures. Semin Oncol 29: 21–33

    Article  CAS  Google Scholar 

  4. De Gramont A et al. (2004) OPTIMOX study: FOLFOX 7/LV5FU2 compared to FOLFOX 4 in patients with advanced colorectal cancer [abstract]. Proc Am Soc Clin Oncol 23: a3525

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paulo M Hoff.

Ethics declarations

Competing interests

Dr Hoff has received a research grant from Sanofi-Synthelabo Inc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoff, P. Oxaliplatin-related neurotoxicity: is chelation the solution?. Nat Rev Clin Oncol 1, 78–79 (2004). https://doi.org/10.1038/ncponc0043

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0043

  • Springer Nature Limited

Navigation